Telescope

Telescope quantifies transposable element (TE) expression from RNA-seq data to characterize the retrotranscriptome, resolving ambiguously mapped fragments including human endogenous retroviruses (HERVs).


Key Features:

  • Accurate estimation of TE expression: Provides precise quantification of transposable element expression at specific genomic locations, addressing ambiguously mapped RNA-seq fragments.
  • Bayesian statistical model: Employs a Bayesian framework to probabilistically reassign ambiguous fragments to the most probable source transcript.
  • High resolution insertion-level analysis: Estimates expression at specific TE insertions rather than only at the subfamily level.
  • Robustness across sequencing technologies: Maintains consistent performance across different sequencing technologies.
  • Comparative analysis capability: Has been compared to unique counts, best counts, RepEnrich, TEtranscripts, RSEM, and SalmonTE and demonstrates superior resolution and accuracy.

Scientific Applications:

  • Cell type identification: Resolves retrotranscriptome expression at genomic locations to reveal differential TE expression patterns across cell types.
  • Transposable element biology: Enables discovery of complex TE expression patterns and locus-specific regulation across biological systems.

Methodology:

Probabilistic reassignment of ambiguously mapped RNA-seq fragments using a Bayesian statistical model to estimate locus-specific TE expression.

Topics

Details

License:
MIT
Programming Languages:
Shell, R, Python
Added:
1/9/2020
Last Updated:
1/16/2021

Operations

Publications

Bendall ML, de Mulder M, Iñiguez LP, Lecanda-Sánchez A, Pérez-Losada M, Ostrowski MA, Jones RB, Mulder LCF, Reyes-Terán G, Crandall KA, Ormsby CE, Nixon DF. Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression. PLOS Computational Biology. 2019;15(9):e1006453. doi:10.1371/journal.pcbi.1006453. PMID:31568525. PMCID:PMC6786656.

PMID: 31568525
PMCID: PMC6786656
Funding: - National Cancer Institute: CA206488 - National Institute of Allergy and Infectious Diseases: AI076059, P30AI117970 - National Institutes of Health: UL1TR001876 - National Institute of General Medical Sciences: GM113886

Documentation

Links